Free shipping on all orders $250CAD or more within Canada.

Melanotan II 10 mg

  • HOME
  • |
  • Melanotan II 10 mg

Melanotan II 10 mg

SKU ML102607A

Melanotan II is a synthetic cyclic melanocortin peptide analogue developed from research into alpha-melanocyte-stimulating hormone (α-MSH). It is primarily investigated for its activity at melanocortin receptors involved in pigmentation, appetite regulation, energy balance, and neuroendocrine signaling. One of its best-known research effects is stimulation of melanogenesis through activation of the melanocortin-1 receptor, which can increase melanin production in experimental models. Melanotan II also interacts with central melanocortin receptors, particularly MC3R and MC4R, making it relevant to studies involving appetite, metabolism, and sexual-response pathways. Early human research explored its effects on skin pigmentation and erectile responses, but these findings do not establish it as an approved therapeutic product. Because Melanotan II is a non-selective melanocortin agonist, researchers use it to study how different melanocortin receptor subtypes contribute to diverse physiological processes. Its cyclic structure provides greater resistance to enzymatic breakdown than native α-MSH. This material is intended for laboratory research only, is not authorized by Health Canada for human therapeutic use, and is not intended for human or veterinary administration.


CA$49.99

In Stock

Choose a kit option to save more, or skip this and buy individually above.

Save 10%
2 Vials x 10mg
CA$90.00 CA$100.00
Save 15%
4 Vials x 10mg
CA$170.00 CA$200.00
Save 20%
6 Vials x 10mg
CA$240.00 CA$300.00
Save 30%
10 Vials x 10mg
CA$350.00 CA$500.00
HPLC Purity Verified
Batch Documented
LC-MS Confirmation Available
2°C Storage

*LC-MS identity confirmation may be performed when analytical review indicates conflicting, atypical, or inconclusive results.

Melanotan II

Overview

Melanotan II, commonly abbreviated MT-II or MT2, is a synthetic cyclic peptide analogue of alpha-melanocyte-stimulating hormone (α-MSH).

α-MSH is an endogenous peptide derived from the larger precursor protein proopiomelanocortin (POMC) and is involved in melanocortin receptor signaling throughout the body.

Melanotan II was designed to retain melanocortin receptor activity while improving resistance to enzymatic degradation compared with native α-MSH.

Its research applications extend beyond pigmentation because melanocortin receptors participate in a wide range of biological functions, including:

  • melanogenesis;
  • appetite regulation;
  • energy homeostasis;
  • neuroendocrine signaling;
  • sexual-response pathways;
  • autonomic function;
  • inflammatory regulation.

Melanotan II is therefore best understood as a broad melanocortin receptor agonist rather than solely as a pigmentation compound.


Relationship to Alpha-MSH

Alpha-MSH is a naturally occurring melanocortin peptide that binds to several members of the melanocortin receptor family.

Native α-MSH contains a central amino-acid sequence responsible for much of its receptor-binding activity.

Melanotan II was developed by modifying this pharmacophore and creating a cyclic peptide structure.

Cyclization can:

  • increase structural rigidity;
  • improve receptor interaction;
  • reduce enzymatic degradation;
  • extend biological activity in experimental systems.

This makes Melanotan II substantially more stable than native α-MSH in many laboratory environments.


Peptide Structure

Melanotan II is a cyclic heptapeptide.

Its commonly represented structure is:

Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH₂

Several structural features are important.

Nle — Norleucine

Norleucine is a non-standard amino-acid analogue used in peptide design.

Its inclusion improves stability compared with methionine-containing sequences that may be more susceptible to oxidation.


D-Phenylalanine

Melanotan II includes D-phenylalanine, rather than the naturally occurring L-form.

D-amino-acid substitution can increase resistance to enzymatic degradation and alter receptor-binding properties.

This modification is one reason Melanotan II is more persistent in experimental systems than native α-MSH.


Cyclic Structure

The cyclic portion of Melanotan II is produced by linking residues within the peptide.

This conformational constraint helps stabilize the biologically active shape of the molecule.

Cyclic peptides are often studied because they can exhibit:

  • greater structural stability;
  • increased receptor affinity;
  • reduced enzymatic breakdown;
  • improved conformational selectivity.

Melanocortin Receptor System

Melanotan II interacts with several members of the melanocortin receptor family.

These receptors are G-protein-coupled receptors and include:

  • MC1R;
  • MC2R;
  • MC3R;
  • MC4R;
  • MC5R.

Melanotan II is most relevant to research involving MC1R, MC3R, MC4R, and MC5R.

Because the compound is not highly selective for a single receptor subtype, different biological effects can occur depending on the tissue being studied.


MC1R — Pigmentation Research

The melanocortin-1 receptor (MC1R) is strongly associated with melanocyte biology.

Melanocytes are specialized cells responsible for producing the pigment melanin.

When MC1R is activated, intracellular signaling can increase activity of enzymes involved in melanogenesis.

This makes Melanotan II a widely studied research compound in:

  • melanocyte signaling;
  • melanin production;
  • pigmentation biology;
  • ultraviolet-response research;
  • melanocortin receptor pharmacology.

Melanogenesis Research

Melanogenesis is the biological process through which melanin is synthesized.

Melanin contributes to pigmentation of:

  • skin;
  • hair;
  • eyes.

Melanotan II research commonly examines increases in melanogenic signaling through MC1R.

Important research pathways include:

MC1R activation

↓

cAMP signaling

↓

melanogenic gene expression

↓

increased melanin synthesis

This pathway makes Melanotan II useful for studying the molecular regulation of pigmentation.


UV and Photobiology Research

Melanin plays a role in the skin's response to ultraviolet exposure.

Because Melanotan II can stimulate melanogenesis, researchers have investigated melanocortin signaling in the context of:

  • UV exposure;
  • pigmentation responses;
  • melanocyte adaptation;
  • photobiology;
  • cellular responses to radiation stress.

Increased pigmentation should not automatically be interpreted as complete protection against ultraviolet injury.

Melanotan II is not a replacement for conventional UV-protection strategies.


MC3R and Metabolic Research

The melanocortin-3 receptor (MC3R) is expressed in parts of the central nervous system and is involved in energy-balance regulation.

Research involving MC3R examines:

  • nutrient sensing;
  • energy distribution;
  • feeding behavior;
  • metabolic homeostasis.

Because Melanotan II can activate MC3R, it is used experimentally to study how melanocortin signaling influences metabolic regulation.


MC4R — Appetite and Energy Balance Research

The melanocortin-4 receptor (MC4R) is one of the most extensively studied receptors in appetite and body-weight biology.

MC4R signaling contributes to regulation of:

  • appetite;
  • satiety;
  • energy expenditure;
  • body-weight control;
  • autonomic output.

Melanotan II has therefore been used in experimental models investigating how melanocortin activation influences feeding behavior and metabolism.

These findings are mechanistic and do not establish Melanotan II as an approved weight-management therapy.


Appetite Research

Experimental studies involving Melanotan II have investigated reductions in food intake associated with central melanocortin signaling.

This area of research helped establish the importance of MC4R in appetite regulation.

Researchers may evaluate:

  • food consumption;
  • satiety signaling;
  • hypothalamic activity;
  • metabolic responses;
  • body-weight changes in animal models.

Melanotan II is useful in this context because it activates multiple melanocortin pathways simultaneously.


Sexual-Response Research

One of the more unusual research observations involving Melanotan II is its effect on sexual-response pathways.

Early clinical investigation reported erectile responses in some human subjects.

This effect appears to be associated primarily with central nervous-system melanocortin signaling rather than direct vascular stimulation.

Research interest includes:

  • MC4R signaling;
  • central sexual arousal pathways;
  • autonomic responses;
  • erectile physiology;
  • neuroendocrine signaling.

This research contributed to development of more selective melanocortin compounds for sexual-function investigation.


Central Nervous System Research

Melanocortin receptors are widely distributed in several brain regions.

Melanotan II is therefore used experimentally to study central melanocortin pathways involved in:

  • feeding behavior;
  • sexual function;
  • autonomic control;
  • stress responses;
  • neuroendocrine regulation.

The compound's ability to activate multiple melanocortin receptor subtypes makes it useful in mechanistic neuroscience models.


Neuroendocrine Research

Melanocortin signaling connects nervous-system activity with endocrine responses.

Melanotan II research can therefore involve:

  • hypothalamic signaling;
  • autonomic function;
  • hormonal regulation;
  • energy homeostasis;
  • behavioral physiology.

These interconnected pathways explain why a melanocortin agonist can influence seemingly unrelated biological systems.


MC5R Research

The melanocortin-5 receptor (MC5R) is expressed in several peripheral tissues.

Research involving MC5R includes:

  • exocrine gland function;
  • immune signaling;
  • sebaceous-gland biology;
  • peripheral melanocortin signaling.

Melanotan II can interact with MC5R and may therefore be useful in studies examining these less-characterized melanocortin pathways.


Inflammatory and Immune Research

Melanocortin peptides are also associated with immunomodulatory signaling.

Although Melanotan II is primarily studied for pigmentation and central melanocortin effects, researchers also investigate melanocortin pathways in relation to:

  • inflammatory signaling;
  • immune-cell function;
  • cytokine regulation;
  • tissue stress responses.

These effects remain highly dependent on receptor subtype and experimental model.


Receptor Signaling

Melanocortin receptors generally signal through G-protein-coupled pathways.

A simplified pathway can be represented as:

Melanotan II

↓

Melanocortin receptor activation

↓

Adenylyl cyclase activation

↓

Increased cyclic AMP (cAMP)

↓

Protein kinase A signaling

↓

Changes in gene expression and cellular activity

The exact response depends on receptor subtype and tissue.


Research Significance

Melanotan II became an important research molecule because it demonstrated that melanocortin signaling controls considerably more than pigmentation.

Its experimental effects helped researchers study relationships between:

pigmentation → metabolism → appetite → neuroendocrine signaling → sexual response

This broad biological activity has also encouraged development of newer melanocortin compounds with greater receptor selectivity.

SpecificationDetails
Compound NameMelanotan II
Common AbbreviationMT-II / MT2
Chemical ClassSynthetic cyclic heptapeptide
Parent Peptideα-Melanocyte-Stimulating Hormone analogue
Nominal Strength10 mg per vial
Physical FormLyophilized powder
CAS Number121062-08-6
Molecular FormulaC₅₀H₆₉N₁₅O₉
Molecular WeightApproximately 1024.2 g/mol
Research ClassificationMelanocortin receptor agonist

Peptide Sequence

The commonly reported Melanotan II structure is:

Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH₂

The peptide contains seven principal amino-acid residues and is structurally constrained through cyclization.


Chemical Classification

Melanotan II is a synthetic cyclic melanocortin peptide analogue.

Its cyclic structure differentiates it from linear melanocortin peptides and contributes to increased stability and receptor activity in experimental systems.


Primary Molecular Targets

MC1R

Research association:

  • melanogenesis;
  • pigmentation;
  • melanocyte signaling.

MC3R

Research association:

  • energy homeostasis;
  • metabolic regulation.

MC4R

Research association:

  • appetite;
  • satiety;
  • energy expenditure;
  • central sexual-response pathways.

MC5R

Research association:

  • peripheral melanocortin signaling;
  • glandular and immune biology.

Primary Research Areas

Melanotan II is commonly investigated in:

Pigmentation Research

  • melanogenesis;
  • melanocyte activity;
  • melanin production;
  • MC1R signaling.

Metabolic Research

  • appetite regulation;
  • food intake;
  • energy balance;
  • hypothalamic melanocortin pathways.

Neuroendocrine Research

  • central melanocortin signaling;
  • autonomic responses;
  • hormonal pathways.

Sexual-Function Research

  • central arousal pathways;
  • MC4R signaling;
  • erectile-response mechanisms.

Receptor Pharmacology

  • melanocortin receptor activity;
  • receptor selectivity;
  • peptide-receptor interaction.

Mechanism of Research Interest

Melanotan II functions primarily as a melanocortin receptor agonist.

A simplified mechanism can be represented as:

Melanotan II

↓

MC1R / MC3R / MC4R / MC5R activation

↓

cAMP-dependent intracellular signaling

↓

Tissue-specific biological response

Possible research outcomes vary substantially depending on which receptor subtype is expressed in the tissue being studied.


Molecular Characteristics

Peptide type: Cyclic heptapeptide

Molecular formula: C₅₀H₆₉N₁₅O₉

Molecular weight: Approximately 1024.2 g/mol

CAS number: 121062-08-6

Nominal vial strength: 10 mg

Chemical class: Melanocortin peptide analogue

Physical Presentation

Form: Lyophilized powder

Nominal content: 10 mg per vial

Compound type: Synthetic cyclic peptide

Primary research category: Melanocortin receptor research

Presentation: Research vial

Lyophilization is commonly used with research peptides to remove water and improve stability during appropriate storage.


Solubility and Laboratory Preparation

Melanotan II is typically handled in aqueous laboratory systems.

Specific solvent selection, concentration, pH, and experimental preparation should be determined by the individual research protocol.

Relevant experimental variables include:

  • solvent composition;
  • concentration;
  • pH;
  • temperature;
  • light exposure;
  • storage duration;
  • freeze-thaw cycles.

These parameters should remain standardized across experimental groups.


Storage and Handling

General laboratory considerations include:

  • maintain appropriate refrigerated storage where specified;
  • protect from excessive heat;
  • minimize unnecessary light exposure;
  • reduce prolonged moisture exposure;
  • avoid repeated temperature fluctuations;
  • use clean laboratory handling procedures;
  • prevent contamination.

Storage conditions should be selected according to the requirements of the individual experimental protocol.


Research Model Applications

Melanotan II may be relevant to controlled laboratory investigations involving:

  • melanocortin receptor pharmacology;
  • melanocyte biology;
  • melanin synthesis;
  • pigmentation pathways;
  • appetite signaling;
  • metabolic regulation;
  • neuroendocrine pathways;
  • sexual-response biology;
  • autonomic signaling;
  • central nervous-system melanocortin research.

Experimental Endpoints

Researchers may examine endpoints such as:

Pigmentation Endpoints

  • melanin content;
  • melanogenic enzyme activity;
  • melanocyte signaling;
  • pigmentation changes.

Receptor Endpoints

  • MC1R activation;
  • MC3R signaling;
  • MC4R signaling;
  • intracellular cAMP.

Metabolic Endpoints

  • food intake;
  • satiety;
  • energy expenditure;
  • hypothalamic signaling.

Neuroendocrine Endpoints

  • autonomic responses;
  • behavioral changes;
  • receptor-specific central signaling.

Intended Research Use

Melanotan II 10 mg is intended for controlled laboratory research involving:

  • melanocortin biology;
  • pigmentation research;
  • receptor pharmacology;
  • metabolic signaling;
  • neuroendocrine research;
  • melanocyte biology;
  • appetite-related pathways;
  • sexual-response mechanisms;
  • preclinical pharmacology.

Available evidence includes animal research and limited early human investigation. These findings should not automatically be interpreted as establishing therapeutic efficacy or safety.


Regulatory Status

Melanotan II remains an investigational research compound.

It is not authorized by Health Canada for human or veterinary use.

The product is intended strictly for laboratory and research purposes and is not intended for clinical, diagnostic, therapeutic, cosmetic, or veterinary administration.



TESTING METHODOLOGY

Each batch undergoes analytical review using validated laboratory procedures. HPLC testing is utilized to assess purity and compare the sample profile against established reference standards. Where additional verification is warranted, LC-MS analysis may be performed to support compound identity confirmation.

OUR ANALYTICAL VERIFICATION PROGRAM

  • Primary Testing: HPLC purity analysis and reference comparison
  • Identity Confirmation: LC-MS performed when indicated*
  • Quality Standards: Batch traceability, analytical documentation, third-party testing and storage procedures

*See LC-MS Confirmation Information for full details.

Every batch supplied by Vanguard Compound Research is assigned a unique batch number and maintained under documented quality-control procedures with supporting analytical documentation available upon request.

SHIPPING & FULFILLMENT

FULFILLMENT INFORMATION
Ships from Canada

All orders ship from within Canada.

Batch Documentation Available

Batch records and analytical documentation may be provided for qualifying products.

Secure Packaging

Products are packaged securely to ensure safe delivery.

Tracking Provided

Tracking information is provided for every shipment.

Temperature-Conscious Handling

Frozen or ambient-safe packaging used as appropriate.

All Vanguard Compound Research orders are shipped directly from within Canada, ensuring efficient delivery, reliable service, and consistent quality-control from fulfillment to arrival.

Canadian Researchers Benefit From:

  • Domestic shipping with no customs delays
  • Batch-specific third-party laboratory testing
  • Full lot number traceability on every product
  • Access to batch-specific Certificates of Analysis (COAs)
  • Dedicated customer support

Canada-Wide Fulfillment:

  • Orders processed Monday through Friday
  • Shipments dispatched throughout Canada
  • Discreet and secure packaging
  • Tracking provided with every shipment

Batch Documentation & Testing

Products are maintained under documented quality-control procedures to help ensure quality, consistency, and transparency.

  • HPLC purity analysis
  • Reference-standard comparison
  • Additional verification procedures (e.g. LC-MS confirmation) may be performed where warranted
  • Lot number traceability

Each product is assigned a unique lot number, allowing researchers to match their item directly to its corresponding Certificate of Analysis (COA).

Analytical Documentation

Supporting analytical documentation may be available for qualifying products, including batch-specific quality records and testing information.

Documentation may include:
  • Batch Number
  • Analytical Results
  • Traceability Records
  • Storage Information

RELATED PRODUCTS